REFERENCES
1. Hazarika N, Rajaprabha RK. Assessment of Life Quality Index Among
Patients with Acne Vulgaris in a Suburban Population. Indian J
Dermatol . 2016;61(2):163-168.
2. Gollnick HP, Zouboulis CC. Not all acne is acne vulgaris. Dtsch
Arztebl Int . 2014;111(17):301-312.
3. Stokes, JH, Pillsbury DM.The effect on the skin of emotional and
nervous states: iII. Theoretical and practical consideration of a
gastro-intestinal mechanism.Arch Derm
Syphilol. 1930;22(6):962-993.
4. Kennedy PJ, Cryan JF, Quigley EM, Dinan TG, Clarke G. A sustained
hypothalamic-pituitary-adrenal axis response to acute psychosocial
stress in irritable bowel syndrome. Psychol Med .
2014;44(14):3123-3134.
5. Sweetser S, Camilleri M, Linker Nord SJ, et al. Do corticotropin
releasing factor-1 receptors influence colonic transit and bowel
function in women with irritable bowel syndrome?. Am J Physiol
Gastrointest Liver Physiol . 2009;296(6):G1299-G1306
6. Mearin F, Lacy BE, Chang L, et al. Bowel Disorders [published
online ahead of print, 2016 Feb 18]. Gastroenterology .
2016;S0016-5085(16)00222-5.
7. Holtmann GJ, Ford AC, Talley NJ. Pathophysiology of irritable bowel
syndrome. Lancet Gastroenterol Hepatol . 2016;1(2):133-146
8. Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading
systems and proposal of a novel system. Int J Dermatol .
1997;36(6):416-418.
9. Aydemir Ö, Guvenir T, Kuey L, Kultur S. Validity and reliability of
Turkish version of hospital anxiety and depression scale. Turk
Psikiyatri Derg isi 1997;8 (4):280-7.
10. Guiné RP, Duarte J, Ferreira M, et al. Knowledge about dietary
fibres (KADF): development and validation of an evaluation instrument
through structural equation modelling (SEM). Public Health .
2016;138:108-118.
11. Ozgürsoy Uran BN, Vardar R, Karadakovan A, Bor S. The Turkish
version of the Rome III criteria for IBS is valid and
reliable. Turk J Gastroenterol . 2014;25(4):386-392
12 Drossman DA, Dumitrascu DL. Rome III: New standard for functional
gastrointestinal disorders. J Gastrointestin Liver Dis .
2006;15(3):237-241.
13. Lee PH, Macfarlane DJ, Lam TH, Stewart SM. Validity of the
International Physical Activity Questionnaire Short Form (IPAQ-SF): a
systematic review. Int J Behav Nutr Phys Act . 2011;8:115.
14. Samuels DV, Rosenthal R, Lin R, Chaudhari S, Natsuaki MN. Acne
vulgaris and risk of depression and anxiety: A meta-analytic
review. J Am Acad Dermatol . 2020;83(2):532-541
15 Bowe W, Patel NB, Logan AC. Acne vulgaris, probiotics and the
gut-brain-skin axis: from anecdote to translational
medicine. Benef Microbes . 2014;5(2):185-199.
16 Arck P, Handjiski B, Hagen E, et al. Is there a ’gut-brain-skin
axis’?. Exp Dermatol . 2010;19(5):401-405.
17 Bercik P, Collins SM. The effects of inflammation, infection and
antibiotics on the microbiota-gut-brain axis. Adv Exp Med Biol .
2014;817:279-289.
18 Rokowska-Waluch A, Pawlaczyk M, Cybulski M, et al. Stressful Events
and Serum Concentration of Substance P in Acne Patients. Ann
Dermatol . 2016;28(4):464-469.
19 Ford AC, Lacy BE, Talley NJ. Irritable Bowel Syndrome. N Engl J
Med . 2017;376(26):2566-2578.
20 Barbara G, Cremon C, Annese V, et al. Randomised controlled trial of
mesalazine in IBS. Gut . 2016;65(1):82-90.
21. Choghakhori R, Abbasnezhad A, Hasanvand A, Amani R. Inflammatory
cytokines and oxidative stress biomarkers in irritable bowel syndrome:
Association with digestive symptoms and quality of
life. Cytokine . 2017;93:34-43.
22. Addolorato G, Mirijello A, D’Angelo C, et al. State and trait
anxiety and depression in patients affected by gastrointestinal
diseases: psychometric evaluation of 1641 patients referred to an
internal medicine outpatient setting. Int J Clin Pract .
2008;62(7):1063-1069.
23. Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal
bacterial overgrowth reduces symptoms of irritable bowel
syndrome. Am J Gastroenterol . 2000;95(12):3503-3506.
24 Demirbaş A, Elmas ÖF. The relationship between acne vulgaris and
irritable bowel syndrome: A preliminary study [published online ahead
of print, 2020 May 28]. J Cosmet Dermatol .
2020;10.1111/jocd.13481.
25 Bai T, Xia J, Jiang Y, et al. Comparison of the Rome IV and Rome III
criteria for IBS diagnosis: A cross-sectional survey. J
Gastroenterol Hepatol . 2017;32(5):1018-1025.
26 Ghoshal UC. Pros and Cons While Looking Through an Asian Window on
the Rome IV Criteria for Irritable Bowel Syndrome: Pros. J
Neurogastroenterol Motil . 2017;23(3):334-340.
27 Shalom G, Magen E, Babaev M, et al. Chronic urticaria and irritable
bowel syndrome: a cross-sectional study of 11 271 patients. Br J
Dermatol . 2018;178(3):e204-e206.
28 Kim M, Choi KH, Hwang SW, Lee YB, Park HJ, Bae JM. Inflammatory bowel
disease is associated with an increased risk of inflammatory skin
diseases: A population-based cross-sectional study. J Am Acad
Dermatol . 2017;76(1):40-48.
29 Alshammrie FF, Alshammari R, Alharbi RM, Khan FH, Alshammari SK.
Epidemiology of Acne Vulgaris and Its Association With Lifestyle Among
Adolescents and Young Adults in Hail, Kingdom of Saudi Arabia: A
Community-Based Study. Cureus . 2020;12(7):e9277
30 Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity
risk factors of acne in high school pupils: a community-based
study. J Invest Dermatol . 2009;129(9):2136-2141.
31 Kucharska A, Szmurło A, Sińska B. Significance of diet in treated and
untreated acne vulgaris. Postepy Dermatol Alergol .
2016;33(2):81-86
32 Kaufman WH. The diet and acne. Arch Dermatol . 1983;119(4):276.
33 Smith RN, Mann NJ, Braue A, Mäkeläinen H, Varigos GA. A
low-glycemic-load diet improves symptoms in acne vulgaris patients: a
randomized controlled trial. Am J Clin Nutr . 2007;86(1):107-115.
34 Sas K, Reich A. High Body Mass Index is a Risk Factor for Acne
Severity in Adolescents: A Preliminary Report. Acta Dermatovenerol
Croat . 2019;27(2):81-85.
35 Firooz A, Sarhangnejad R, Davoudi SM, Nassiri-Kashani M. Acne and
smoking: is there a relationship?. BMC Dermatol . 2005;5:2.
36 Capitanio B, Sinagra JL, Ottaviani M, Bordignon V, Amantea A, Picardo
M. Acne and smoking. Dermatoendocrinol . 2009;1(3):129-135.
37 Schäfer T, Nienhaus A, Vieluf D, Berger J, Ring J. Epidemiology of
acne in the general population: the risk of smoking. Br J
Dermatol . 2001;145(1):100-104
38 Helvaci M. R, Ayyildiz O, Algin M.C., Aydin Y, Abyad A,Pocock, L.
Irritable bowel syndrome and smoking. World Family Medicine
Journal: Incorporating the Middle East Journal of Family Medicine .
2017; 99 (5588): 1-5.
39 Bray ER, Kirsner RS, Issa NT. Coffee and skin-Considerations beyond
the caffeine perspective. J Am Acad Dermatol . 2020;82(2):e63.
Table 1 . Socio-demographic characteristics of the participants